SG11202000141WA - Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof - Google Patents

Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof

Info

Publication number
SG11202000141WA
SG11202000141WA SG11202000141WA SG11202000141WA SG11202000141WA SG 11202000141W A SG11202000141W A SG 11202000141WA SG 11202000141W A SG11202000141W A SG 11202000141WA SG 11202000141W A SG11202000141W A SG 11202000141WA SG 11202000141W A SG11202000141W A SG 11202000141WA
Authority
SG
Singapore
Prior art keywords
international
milano
solid dispersions
viale
indena
Prior art date
Application number
SG11202000141WA
Other languages
English (en)
Inventor
Massimo Ronchi
Elisabetta Frattini
Antonella Riva
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of SG11202000141WA publication Critical patent/SG11202000141WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
SG11202000141WA 2017-07-17 2018-07-16 Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof SG11202000141WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17181634 2017-07-17
PCT/EP2018/069284 WO2019016146A1 (en) 2017-07-17 2018-07-16 SOLID POWDER DISPERSIONS COMPRISING QUERCETIN, PROCESS FOR PREPARING SAME AND FORMULAS THEREOF

Publications (1)

Publication Number Publication Date
SG11202000141WA true SG11202000141WA (en) 2020-02-27

Family

ID=59381081

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202000141WA SG11202000141WA (en) 2017-07-17 2018-07-16 Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof

Country Status (17)

Country Link
US (1) US11331298B2 (cg-RX-API-DMAC7.html)
EP (1) EP3654938B1 (cg-RX-API-DMAC7.html)
JP (1) JP7284743B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200030076A (cg-RX-API-DMAC7.html)
CN (1) CN110944624A (cg-RX-API-DMAC7.html)
AU (1) AU2018304534B2 (cg-RX-API-DMAC7.html)
CA (1) CA3069055A1 (cg-RX-API-DMAC7.html)
DK (1) DK3654938T3 (cg-RX-API-DMAC7.html)
ES (1) ES2929981T3 (cg-RX-API-DMAC7.html)
FI (1) FI3654938T3 (cg-RX-API-DMAC7.html)
HU (1) HUE060387T2 (cg-RX-API-DMAC7.html)
IL (1) IL271852B2 (cg-RX-API-DMAC7.html)
PL (1) PL3654938T3 (cg-RX-API-DMAC7.html)
PT (1) PT3654938T (cg-RX-API-DMAC7.html)
SG (1) SG11202000141WA (cg-RX-API-DMAC7.html)
SI (1) SI3654938T1 (cg-RX-API-DMAC7.html)
WO (1) WO2019016146A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210393579A1 (en) * 2020-06-23 2021-12-23 Zestt Wellness Limited Anthocyanin and Quercetin Based Formulations for Improved Respiratory Health
JP7123434B1 (ja) 2021-03-17 2022-08-23 株式会社アイビー化粧品 破骨細胞分化抑制剤
CN113712988A (zh) * 2021-08-17 2021-11-30 塔里木大学 一种槲皮素-替米考星聚合物纳米微粒、其制备方法及应用
IT202200002108A1 (it) 2022-02-07 2023-08-07 Indena Spa Composizioni a base di quercetina per il trattamento e la prevenzione di affezioni oculari
KR102653457B1 (ko) * 2023-12-20 2024-04-02 서울대학교산학협력단 장 점막 부착성이 향상된 쿼세틴 함유 분말 제제의 제조방법 및 이에 따라 제조된 쿼세틴 함유 분말 제제
KR20260108310A (ko) * 2024-12-30 2026-07-08 대상웰라이프 주식회사 구강 건강 개선용 조성물의 제조 방법 및 이로부터 제조된 구강 건강 개선용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100370968C (zh) * 2005-12-06 2008-02-27 四川大学 槲皮素长效脂质体粉针剂及其制备方法
CN100367953C (zh) * 2006-03-06 2008-02-13 山东大学 槲皮素固体脂质纳米粒制剂及其制备方法
CN101904821A (zh) * 2009-06-02 2010-12-08 姜玲敏 槲皮素纳米冻干粉及其制备方法
CN102058536A (zh) 2011-01-14 2011-05-18 四川大学 槲皮素羟丙基β-环糊精包和物脂质体及其制备方法和用途

Also Published As

Publication number Publication date
EP3654938B1 (en) 2022-08-31
IL271852A (en) 2020-02-27
HUE060387T2 (hu) 2023-02-28
IL271852B1 (en) 2024-03-01
AU2018304534B2 (en) 2024-07-11
CN110944624A (zh) 2020-03-31
JP7284743B2 (ja) 2023-05-31
IL271852B2 (en) 2024-07-01
JP2020527549A (ja) 2020-09-10
RU2020106924A3 (cg-RX-API-DMAC7.html) 2021-11-17
AU2018304534A1 (en) 2020-02-06
US11331298B2 (en) 2022-05-17
RU2020106924A (ru) 2021-08-17
SI3654938T1 (sl) 2022-11-30
KR20200030076A (ko) 2020-03-19
PT3654938T (pt) 2022-11-03
FI3654938T3 (fi) 2022-12-15
BR112020000841A2 (pt) 2020-07-21
CA3069055A1 (en) 2019-01-24
WO2019016146A1 (en) 2019-01-24
US20200206186A1 (en) 2020-07-02
PL3654938T3 (pl) 2022-12-27
EP3654938A1 (en) 2020-05-27
ES2929981T3 (es) 2022-12-05
DK3654938T3 (da) 2022-10-03

Similar Documents

Publication Publication Date Title
SG11201906431UA (en) Method for the treatment of thromboembolism
SG11201807660QA (en) Cyclic di-nucleotide compounds and methods of use
SG11201811442UA (en) Formulation of a peptide vaccine
SG11201908971RA (en) Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene
SG11201909963YA (en) Methods for treating dravet syndrome
SG11201807809XA (en) A transient commensal microorganism for improving gut health
SG11201901986SA (en) Process for the manufacture of a solid pharmaceutical adminstration form
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201807912SA (en) Vaccine against rsv
SG11201808108XA (en) Synthesis of indazoles
SG11201907804QA (en) Pharmaceutical composition comprising selexipag
SG11201809594WA (en) Nicotine particles and compositions
SG11201808710UA (en) Novel immunogenic cd1d binding peptides
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201809830WA (en) Selective reduction of cysteine-engineered antibodies
SG11201810965YA (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
SG11201900021PA (en) Methods and compositions for the treatment of cancer
SG11201808686VA (en) Synthesis of indazoles
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201810078PA (en) Stabilized pre-fusion rsv f proteins
SG11201907927SA (en) Binding molecules that specifically bind to tau
SG11201908422YA (en) Glycopolymers sequestering carbohydrate-binding proteins
SG11201811246RA (en) Novel silybum marianum achene extract and uses thereof in dermatology and dermo-cosmetics
SG11201807963WA (en) Compositions useful in the prevention and/or treatment of disorders of the oral cavity, upper airways and esophagus
SG11201809882XA (en) Pharmaceutical combinations for treating cancer